[1] |
HE Chong, ZHOU Shu-rui, LI Ya-qing, CHEN Shao-jie, LIAN Guo-da, CHEN Shang-xiang, HUANG Kai-hong.
Screening of ferroptosis-related genes and construction of prognostic prediction model in pancreatic cancer
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 14-23.
|
[2] |
WU Ye, LIU Xiao-di, XU Yan-ni, LUO Bao-ming.
Methionine deficiency increase the drug sensitivity of regorafenibfor hepatocellular carcinoma cells
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 24-29.
|
[3] |
Liu Wei.
Five-year follow-up analysis of clinical efficacy of radiotherapy alone and radiochemotherapy in malignant glioma
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 89-93.
|
[4] |
HUANG Zhan-ren, NING Jin-yue, LI Han-qin, CHEN Nian-ping.
Advances of the conversion therapy of immune checkpoint inhibitors combined antiangiogenic targeted drugs for advanced hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2022, 22(1): 110-114.
|
[5] |
HU Ming-chao, ZHU Bao-song.
Bioinformatics analysis of the diagnostic and prognostic value of the NDC1 gene in colon cancer: a study based on TCGA database
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 598-602.
|
[6] |
SONG Yan-zhou, KANG Zhi-long, SU Yi-nan, ZHANG Yi-ming, ZHAO Xin, LI Zhi-wei, LI Wei.
Expression of NEK7 in patients with primary hepatocellular carcinoma and its clinical significance
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 608-613.
|
[7] |
MA Xiao-wu, TAN Wen-liang, YANG Lei, XIE Zhi-qin, WANG Qing-bin, CHEN Ya-jin, SHANG Chang-zhen.
Experimental study of circKDM4B on the proliferation, migration and invasion of hepatocellular carcinoma cells
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 614-619.
|
[8] |
LU Xu, LI Hua, YI Shu-hong, ZHAO Hui, ZHU Shu-guang, LI Hai-bo, YANG Yang, WANG Guo-ying.
Transarterial chemoembolization combined with Lenvatinib bridging in the treatment of 2 patients with hepatocellular carcinoma exceeding Milan standard liver transplantation
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(05): 507-511.
|
[9] |
WU Juan-hua, TAN Hui-min, ZUO Chao-hai, KUANG Nai-le, YU Jie-xiong, CHEN Yun-yang..
Analysis of TACE on prevention of postoperative recurrence in patient with hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 397-404.
|
[10] |
SU Ru-ping, LI Ni, ZHONG Li, ZHAO Zhi.
Laparoscopic hepatectomy and splenic artery ligation in surgical treatment for cirrhotic patients with hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 415-418.
|
[11] |
WANG Dao-du, ZHAO Qi-jiong, ZHOU Zhi-biao, HE Yong-yue.
Development of the prognosis signature for hepatocellular carcinoma based on ferroptosis-related genes
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 419-424.
|
[12] |
WANG Qing-bin, SHANG Chang-zhen, CHEN Ya-jin.
Progress on the prognosis prediction of hepatocellular carcinoma after liver resection
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 471-476.
|
[13] |
DING Chen-chen, SONG Xing-dong, ZHANG Lei.
2021 ASCO in the vision of liver surgeons
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 265-271.
|
[14] |
ZENG Bing, LI Jin-hong, CAI Can-feng, XIN Hai-yang, ZENG Jun.
The expression and clinical significance of ITGAV in colorectal cancer
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 309-312.
|
[15] |
WU Jun-hua, CHEN Yun-yang, ZHANG Xin, YU Jie-xiong, CUI En-ming, ZHANG Hui-ling.
Expression and clinical value of RNF24 in patients with hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 165-170.
|